List of insiders holdings for INTERCEPT PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Genextra S.p.A. 10% Owner | 2022-09-02 16:58:20 | 4,000,000 0 | 4,000,000 | Form 13G |
| Micheli Francesco 10% Owner | 2020-08-17 20:10:08 | 0 4,000,000 | 4,000,000 | Form 4 |
| SILVERSTEIN JONATHAN Director | 2015-11-27 21:02:38 | 3,009 1,120,324 | 1,123,333 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ISALY SAMUEL D Director | 2015-07-21 21:25:55 | 0 1,120,609 | 1,120,609 | Form 4 |
| Regan Daniel Paul Chief Commercial Officer | 2015-02-03 21:01:10 | 93,292 0 | 93,292 | Form 4 |
| Kapadia Sandip CFO and Treasurer | 2021-01-26 19:01:50 | 67,864 0 | 67,864 | Form 4 |
| Shapiro David Chief Medical Officer | 2019-05-03 19:00:23 | 48,530 0 | 48,530 | Form 4 |
| Campagna Jason Chief Medical Officer | 2021-01-26 19:01:17 | 40,231 0 | 40,231 | Form 4 |
| Cawkwell Gail SVP, Med Affairs, Safety & PV | 2022-02-15 16:48:04 | 35,740 0 | 35,740 | Form 4 |
| Duncan Barbara Gayle Chief Accounting Officer | 2016-10-05 21:04:41 | 30,661 0 | 30,661 | Form 4 |
| Weyer Christian EVP, Research & Development | 2021-04-05 19:03:30 | 27,341 0 | 27,341 | Form 4 |
| BALL BRYAN Chief Qual. Officer & SVP Ops. | 2022-07-13 16:01:33 | 25,178 0 | 25,178 | Form 4 |
| Sullivan Ryan T General Counsel and Secretary | 2020-11-16 19:00:41 | 24,708 0 | 24,708 | Form 4 |
| Bright Lisa President, International | 2020-07-06 19:00:34 | 22,012 0 | 22,012 | Form 4 |
| Kim Richard J President US Comm & Strat Mktg | 2021-01-05 19:01:26 | 19,770 0 | 19,770 | Form 4 |
| McMinn Rachel Chief Strategy Officer | 2017-10-04 21:00:19 | 16,875 0 | 16,875 | Form 4 |
| WELCH DANIEL G Director | 2020-06-01 19:01:07 | 11,026 0 | 11,026 | Form 4 |
| DeFrancesco Lisa SVP, IR & Corp. Affairs | 2022-01-04 16:18:42 | 10,308 0 | 10,308 | Form 4 |
| TALLARIGO LORENZO Director | 2014-07-09 21:00:52 | 4,923 0 | 4,923 | Form 4 |
| VEITINGER KLAUS R DR Director | 2015-11-27 21:01:45 | 4,566 0 | 4,566 | Form 4 |
| WILLIAMS NICOLE Director | 2015-11-23 21:01:15 | 1,936 0 | 1,936 | Form 4 |
| Patel Sanj K Director | 2014-07-21 21:02:04 | 1,003 0 | 1,003 | Form 4 |
| SANTINI GINO Director | 2023-11-13 14:44:58 | 0 0 | 0 | Form 4 |
| AKKARAJU SRINIVAS Director | 2023-11-13 14:51:46 | 0 0 | 0 | Form 4 |
| Venezia Rocco Chief Accounting Officer | 2023-11-13 14:49:33 | 0 0 | 0 | Form 4 |
| Fundaro Paolo Director | 2023-11-13 14:47:18 | 0 0 | 0 | Form 4 |
| Berrey M Michelle President, R&D and CMO | 2023-11-13 14:49:03 | 0 0 | 0 | Form 4 |
| Richardson Linda M EVP & Chief Commercial Officer | 2023-11-13 14:46:53 | 0 0 | 0 | Form 4 |
| Benatti Luca Director | 2023-11-13 14:46:04 | 0 0 | 0 | Form 4 |
| SBLENDORIO GLENN Director | 2023-11-13 14:45:58 | 0 0 | 0 | Form 4 |
| Miller-Rich Nancy Director | 2023-11-13 14:44:09 | 0 0 | 0 | Form 4 |
| Adorini Luciano See Remarks | 2016-02-16 21:00:49 | 0 0 | 0 | Form 4 |
| ROSA-BJORKESON DAGMAR Director | 2023-11-13 14:43:51 | 0 0 | 0 | Form 4 |
| Gottesdiener Keith Michael Director | 2023-11-13 14:43:13 | 0 0 | 0 | Form 4 |
| Ford David A Chief Human Resources Officer | 2023-11-13 14:42:50 | 0 0 | 0 | Form 4 |
| Freedberg Jared General Counsel | 2023-11-13 14:42:02 | 0 0 | 0 | Form 4 |
| BRADBURY DANIEL Director | 2023-11-13 14:41:34 | 0 0 | 0 | Form 4 |
| Durso Jerome Benedict CEO | 2023-11-13 14:40:48 | 0 0 | 0 | Form 4 |
| Pruzanski Mark Director | 2023-11-13 14:40:39 | 0 0 | 0 | Form 4 |
| Saik Andrew EVP & Chief Financial Officer | 2023-11-13 14:40:15 | 0 0 | 0 | Form 4 |